“In the United States, the medical community has made great strides in preventing and controlling cervical cancer. Screening can effectively detect the disease in its earliest, pre-cancerous stages, while the HPV vaccine is highly effective at preventing cervical cancer. That combination has led to a 50% drop in cervical cancer diagnoses in the U.S. from 1975 to 2010. ” – U. of Michigan, Feb 13, 2020
34,000 new cancer cases per year are largely preventable
March 5, 2020
Scientific American – If you’re in a crowded room full of adults, look to your right and to your left.
The person on each side of you—and you, too—have probably been, or currently are, infected with the human papillomavirus (HPV).
HPV is the most common sexually transmitted infection in the U.S.
For most of us, our immune systems will clear the virus.
But if yours fails to do so, and the virus remains in your system, it can cause health problems later in life, including six different types of cancer:
- cervical, vaginal and vulvar cancers in women;
- penile cancer in men;
- and oropharynx (back of the throat) and anal cancers in both women and men.
“An extremely safe and effective vaccine that can prevent these HPV-related cancers”
Every year in the U.S., HPV is estimated to cause over 34,000 new cases of cancer and according to the World Health Organization over 570,000 new cases of HPV-associated cervical cancer are newly diagnosed around the world each year.
Since 2006 there has been an extremely safe and effective vaccine that can prevent these HPV-related cancers.
The HPV vaccine has typically been administered to girls and boys at the age of 11 or 12, because it is most effective when administered at an early age and prior to exposure to the virus.
The original recommendations also encouraged men and women up to age 26 to get vaccinated.
More recent recommendations from the U.S. Food and Drug Administration expanded the approval of the vaccine through 45 years of age for women and men who have not been previously vaccinated.
Following on the FDA recommendations, in June 2019 the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) also further endorsed this view … Read more.